SEC Filing Analysis: Natera, Inc. (NTRA)

Executive Summary

• Trading Significance: Low
• Key Takeaway: Co-Founder and Director Jonathan Sheena liquidated 18,064 shares (~$7.01M) across family trusts under an established Rule 10b5-1 plan.
• Market Impact: Neutral; transaction represents a negligible fraction of shares outstanding.

Company Information

Field	Value
Company	Natera, Inc.
Ticker Symbol	NTRA
CIK	0001604821
Industry	Services - Medical Laboratories

Insider Information

Field	Value
Name	Sheena Jonathan
CIK	0001646649
Title/Position	Co-Founder
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-09-23
Transaction Code	S (Open Market Sale)
Security Type	Common Stock
Shares Involved	18,064
Price Per Share	~$388.01 (Weighted Average)
Total Value	$7,008,972.43
Shares Owned After	239,314 (221,314 direct, 18,000 indirect)
Ownership Type	Indirect (Caraluna 1 & 2 Trusts)

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$7,008,972.43
% of Market Cap	0.013%
Shares Transacted	18,064
% of Shares Outstanding	0.013%
Post-Transaction Ownership	239,314 shares (0.167% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: Against Natera's $53.25B market valuation, a $7.01M transaction is routine insider rebalancing.
• Ownership Concentration: The reporting owner retains 221,314 direct shares and 18,000 shares across the two trusts, maintaining meaningful exposure.
• Dilution Impact: None; transaction is an open-market secondary disposition.

Market Impact Analysis

• Direction: Neutral
• Reasoning: Executed under a Rule 10b5-1 trading arrangement adopted on June 11, 2026, removing discretionary market timing implications.
• Expected Volume Impact: Negligible; 18,064 shares is easily absorbed by average daily volume.
• Sentiment Indicator: Neutral

Additional Context

• Special Circumstances: Conducted in multiple tranches across Caraluna 1 Trust and Caraluna 2 Trust pursuant to a Rule 10b5-1 plan. The reporting person disclaims beneficial ownership over the trust assets except to pecuniary interest.